Unusual phenotype of acute motor sensory axonal neuropathy with ophthalmoplegia, and anti-GD1a, -GD1b and -GM1 antibodies

Q4 Immunology and Microbiology

Clinical and Experimental Neuroimmunology Pub Date : 2022-04-30 DOI:10.1111/cen3.12704

Theodora Afrantou, Vasilios Kimiskidis, Roza Lagoudaki, Thomai Stardeli, Vasileios Papaliagkas, Georgia Zafeiridou, Giannoula Thoma, Zoi Aidoni, Nikolaos Grigoriadis

{"title":"Unusual phenotype of acute motor sensory axonal neuropathy with ophthalmoplegia, and anti-GD1a, -GD1b and -GM1 antibodies","authors":"Theodora Afrantou, Vasilios Kimiskidis, Roza Lagoudaki, Thomai Stardeli, Vasileios Papaliagkas, Georgia Zafeiridou, Giannoula Thoma, Zoi Aidoni, Nikolaos Grigoriadis","doi":"10.1111/cen3.12704","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Acute motor sensory axonal neuropathy (AMSAN) is a severe form of Guillain–Barré syndrome, which typically is not related to ocular palsy, and is pathologically associated with antibodies against GM1 and GD1a gangliosides.</p>\n </section>\n \n <section>\n \n <h3> Case presentation</h3>\n \n <p>We present a patient with a severe, drug-resistant form of AMSAN with ophthalmoplegia related to antiganglioside (anti-GD1a, -GD1b, -GM1) antibodies in the serum and cerebrospinal fluid, and with a poor long-term outcome.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Rare cases of AMSAN with ophthalmoplegia are described in the literature. The present patient is a case of an unusual clinical phenotype of AMSAN, the characteristics of which warn of a serious clinical course that requires timely aggressive treatment.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12704","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Acute motor sensory axonal neuropathy (AMSAN) is a severe form of Guillain–Barré syndrome, which typically is not related to ocular palsy, and is pathologically associated with antibodies against GM1 and GD1a gangliosides.

Case presentation

We present a patient with a severe, drug-resistant form of AMSAN with ophthalmoplegia related to antiganglioside (anti-GD1a, -GD1b, -GM1) antibodies in the serum and cerebrospinal fluid, and with a poor long-term outcome.

Conclusions

Rare cases of AMSAN with ophthalmoplegia are described in the literature. The present patient is a case of an unusual clinical phenotype of AMSAN, the characteristics of which warn of a serious clinical course that requires timely aggressive treatment.

查看原文本刊更多论文

急性运动感觉轴索神经病伴眼麻痹的异常表型，以及抗- GD1a， - GD1b和- GM1抗体

急性运动感觉轴索神经病变(AMSAN)是吉兰-巴罗综合征的一种严重形式，通常与眼性麻痹无关，并且在病理上与针对GM1和GD1a神经节苷脂的抗体相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊